Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide effects on EEG in healthy volunteers
NCT04884893Phase 1Completed
- Sponsor
- Tampere University Hospital
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nitrous oxide in major depressive disorder (MDD) (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Slow wave activity. Started May 2021; status: completed.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04884893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884893.